MENU
AARD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aardvark Therapeutics (AARD) Earnings Date & Reports
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more
A.I. Advisor
published Earnings
AARD is expected to report earnings to rise 4.55% to -68 cents per share on November 12
Q3'26
Est.
$-0.69
Q2'26
Beat
by $0.21
Q1'26
Missed
by $0.22
Q4'25
Missed
by $0.01
Q3'25
Beat
by $0.02
The last earnings report on August 11 showed earnings per share of -66 cents, beating the estimate of -87 cents. With 248.99K shares outstanding, the current market capitalization sits at 25.61M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
4370 La Jolla Village Drive
Phone
+1 858 225-7696
Employees
40
Web
https://www.aardvarktherapeutics.com